The fight against skin cancer has witnessed remarkable strides over the years, transitioning from traditional methods to more advanced, targeted treatment approaches. Skin cancer, encompassing a variety of types such as melanoma, basal cell carcinoma, and squamous cell carcinoma, poses a significant health challenge worldwide. However, the evolution of treatment Read more…
Exploring the Use of Cannabinoids for Mood Disorders, Anxiety, and PTSD In recent years, the potential therapeutic properties of cannabinoids have garnered significant interest within the medical community, particularly in their potential to treat various psychological conditions. A systematic review published in the National Library of Medicine delves deeply into Read more…
In recent years, the discovery and characterization of novel pathways contributing to neural stem cell (NSC) regulation and the promotion of neurogenesis in the adult hippocampus have been areas of intense research. The article titled “Activation of GPR55 increases neural stem cell proliferation and promotes early adult hippocampal neurogenesis”, published Read more…
Is Cannabidiol During Neurodevelopment a Promising Therapy for Autism? The question of whether cannabidiol (CBD), a compound derived from the cannabis plant, could serve as an effective therapy for autism spectrum disorder (ASD) during neurodevelopmental stages is gaining significant attention in the scientific community. As detailed in a comprehensive review Read more…
The therapeutic potential of cannabidiol (CBD), a non-psychoactive component of cannabis, has been increasingly recognized in various biomedical fields. CBD has been shown to possess a wide range of properties beneficial for managing and potentially treating different health conditions. A key review documented in the study, “Cannabidiol as an Emergent Read more…
Recent research delves into the pharmacological landscape of GPR18, a G-protein-coupled receptor, and its activation by cannabinoid compounds. This pivotal study, titled “Activation of GPR18 by cannabinoid compounds: a tale of biased agonism”, unveils the complexities of GPR18’s interaction with cannabinoids, revealing a nuanced mode of action termed biased agonism. Read more…
Psoriasis, a chronic skin condition with no definitive cure, affects millions globally, creating a necessity for innovative treatments. A groundbreaking study published by Journal of Clinical Medicine offers new insights into the potential benefits of cannabidiol (CBD) for psoriasis sufferers. Titled “Cannabidiol Decreases Metalloproteinase Activity and Normalizes Angiogenesis Factor Expression Read more…
Recent research has brought to light the potential of cannabidiol (CBD), a non-psychoactive component of cannabis, for the treatment of anxiety disorders. The study, titled “Cannabidiol as a Potential Treatment for Anxiety Disorders” and published in the journal Neurotherapeutics, provides a comprehensive look into the existing preclinical and clinical evidence Read more…
Glioblastoma multiforme (GBM) is the most aggressive and common form of primary brain tumor in adults, characterized by rapid growth and resistance to conventional therapies. The prognosis for GBM patients is poor, with a median survival time of just over 14 months post-diagnosis. As such, the quest for novel and Read more…
In a groundbreaking study published in the Frontiers in Pharmacology journal, researchers discovered that oral administration of cannabidiol (CBD) may prevent the development of allodyniaβa condition where pain is caused by stimuli that normally do not provoke painβand other neurological impairments in a mouse model of mild traumatic brain injury Read more…